Abstract
Pioglitazone, a specific ligand for peroxisome proliferator-activated receptor gamma (PPAR-γ), was recently implicated in the control of inflammatory processes and in the modulation of the expression of various cytokines such as tumor necrosis factor alpha (TNF-α), but its role in the mechanism of gastric mucosal integrity has not been studied extensively. This study was designed to determine the effect of pioglitazone on gastric mucosal lesions induced in rats by topical application of 100% ethanol and by 3.5 h of water immersion and restraint stress (WRS) with or without pretreatment with indomethacin (5 mg/kg i.p.) to inhibit cyclooxygenase-1 (COX-1) and COX-2 enzyme activities and L-NNA (20 mg/kg i.p.) to suppress nitric oxide (NO)-synthase. In addition, the effect of pioglitazone on ulcer healing in rats with chronic acetic acid ulcers (ulcer area 28 mm2) was determined. Rats were killed 1 h and 3.5 h after ethanol administration or WRS exposure or at day 9 upon ulcer induction, and the number and area of gastric lesions were measured by planimetry, the gastric blood flow (GBF) was determined by H2-gas clearance technique and the mucosal PGE2 generation and gene expression and plasma concentration of TNF-α and IL-1β were also evaluated. Pre-treatment with pioglitazone dose-dependently attenuated gastric lesions induced by 100% ethanol and WRS; the dose reducing these lesions by 50% (ID50) being 10 mg/kg and 7 mg/kg, respectively. The protective effect of pioglitazone was accompanied by the significant rise in the GBF, an increase in PGE2 generation and the significant fall in the plasma TNF-α and IL-1β levels. Strong signals for IL-1β-and TNF-α mRNA were recorded in gastric mucosa exposed to ethanol or WRS, and these effects were significantly decreased by pioglitazone. Indomethacin which suppressed PG generation by about 90%, while augmenting WRS damage, and L-NNA, that suppressed NO-synthase activity, significantly attenuated the protective and hyperaemic activity of this PPAR-γ ligand. In the chronic study, pioglitazone significantly reduced the area of gastric ulcers on day 9 and significantly raised the GBF at the ulcer margin. The acceleration of ulcer healing by PPAR-γ ligand was accompanied by a significant increase in the expression of PECAM-1 protein, a marker of angiogenesis. We conclude that (1) pioglitazone exerts a potent gastroprotective and hyperaemic actions on the stomach involving endogenous PG and NO and attenuation of the expression and release of proinflammatory cytokines TNF-α and IL-1β, and (2) PPAR-γ ligand accelerates ulcer healing, possibly due to the enhancement in angiogenesis at ulcer margin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akimoto, M., Hashimoto, H., Maeda, A., et al. (2002). Roles of angiogenic factors and endothelin-1 in gastric ulcer healing, Clin. Sci. 103(Suppl. 48), 450S–454S.
Auwerx, J. (1999). PPAR-γ, the ultimate thrifty gene, Diabetologia 42, 1033–1049.
Brzozowski, T., Konturek, S. J., Majka, J., et al. (1993). Epidermal growth factor, polyamines, and prostaglandins in healing of stress-induced gastric lesions in rats, Dig. Dis. Sci. 38, 276–283.
Brzozowski, T., Konturek, P. Ch., Konturek, S. J., et al. (1999a). Leptin in gastroprotection induced by cholecystokinin or by a meal. Role of vagal and sensory nerves and nitric oxide, Eur. J. Pharmacol. 374, 263–276.
Brzozowski, T., Konturek, P. C., Konturek, S. J., et al. (1999b). Water extracts of Helicobacter pylori delay healing of chronic gastric ulcers in rats: role of cytokines and gastrin-somatostatin link, Digestion 60, 22–33.
Brzozowski, T., Konturek, P. Ch., Konturek, S. J., et al. (1999c). Acceleration of ulcer healing by cholecystokinin (CCK): role of CCK-A receptors, somatostatin, nitric oxide and sensory nerves, Regul. Pept. 82, 19–33.
Brzozowski, T., Konturek, P. C., Konturek, S. J., et al. (2001a). Effect of local application of growth factors on gastric ulcer healing and mucosal expression of cyclooxygenase-1 and-2, Digestion 64, 15–29.
Brzozowski, T., Konturek, P. C., Konturek, S. J., et al. (2001b). Classic NSAID and selective cyclooxygenase (COX)-1 and COX-2 inhibitors in healing of chronic gastric ulcers, Microsc. Res. Tech. 53, 343–353.
Brzozowski, T., Konturek, P. C., Konturek, S. J., et al. (2003). Implications of reactive oxygen species and cytokines in gastroprotection against stress-induced gastric damage by nitric oxide releasing aspirin, Int. J. Colorect. Dis. 18, 320–329.
Jenkinson, L., Bardhan, K. D., Atherton, J., et al. (2002). Helicobacter pylori prevents proliferative stage of angiogenesis in vitro: role of cytokines, Dig. Dis. Sci. 47, 1857–1862.
Jiang, C., Ting, A. T. and Seed, B. (1998). PPAR-γ agonists inhibit production of monocyte inflammatory cytokines, Nature 391, 82–86.
Kojima, K., Shimada, T., Mitobe, Y., et al. (2002). Effect of PPAR-γ ligands on the viability of gastric epithelial cells, Aliment. Pharmacol. Ther. 16(Suppl. 2), 67–73.
Konturek, P. Ch., Brzozowski, T., Konturek, S. J., et al. (1999). Apoptosis in gastric mucosa with stress-induced gastric ulcers, J. Physiol. Pharmacol. 50, 211–225.
Konturek, P. Ch., Duda, A., Brzozowski, T., et al. (2000). Activation of genes for superoxide dismutase, interleukin-1β, tumor necrosis factor-α, and intercellular adhesion molecule-1 during healing of ischemia-reperfusion-induced gastric injury, Scand. J. Gastroenterol. 35, 452–463.
Konturek, P. C., Brzozowski, T., Ptak, A., et al. (2002). Nitric oxide releasing aspirin protects the gastric mucosa against stress and promotes healing of stress-induced gastric mucosal damage: role of heat shock protein 70, Digestion 66, 160–172.
Konturek, P. C., Brzozowski, T., Kania, J., et al. (2004). Pioglitazone, a specific ligand of peroxisome proliferator-activated receptor-gamma, accelerates gastric ulcer healing in rat, Eur. J. Pharmacol. 472, 213–220.
Konturek, S. J., Brzozowski, T., Majka, J., et al. (1992). Transforming growth factor alpha and epidermal growth factor in protection and healing of gastric mucosal injury, Scand. J. Gastroenterol. 27, 649–655.
Naito, Y., Takagi, T., Matsuyama, K., et al. (2001). Pioglitazone, a specific PPAR-γ ligand, inhibits aspirin-induced gastric mucosal injury in rats, Aliment. Pharmacol. Ther. 15, 865–873.
Nakajima, A., Wada, K., Miki, H., et al. (2001). Endogenous PPAR-γ mediates antiinflammatory activity in murine ischemia-reperfusion injury, Gastroenterology 120, 460–469.
Nakamura, E., Takahashi, S., Ishikawa, M., et al. (1999). Inhibitory effect of macrophage-derived factors on the recovery of wounds induced in rat gastric epithelial cells, Biochem. Pharmacol. 58, 1221–1227.
Newman, P. J. (1997). The biology of PECAM-1, J. Clin. Invest. 99, 3–8.
Okabe, S., Pfeiffer, C. J. and Roth, I. L. A. (1987). A method for experimental penetrating gastric and duodenal ulcers in rats, Digestion 38, 103–113.
Ricote, M., Li, A. C., Willson, T. M., et al. (1988). The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation, Nature 391, 79–82.
Rokutan, K. (2000). Role of heat shock proteins in gastric mucosal protection, J. Gastroenterol. Hepatol. 15(Suppl. 1), D12–D19.
Shimizu, N., Watanabe, T., Arakawa, I., et al. (2000). Pentoxifylline accelerates gastric ulcer healing in rats: roles of tumor necrosis factor alpha and neutrophils during the early phase of ulcer healing, Digestion 61, 157–164.
Simonin, M. A., Bordji, K., Boyault, S., et al. (2002). PPAR-gamma ligands modulate effect of LPS in stimulated rat synovial fibroblasts, Am. J. Physiol. 282, C125–C133.
Straus, D. S., Pascual, G., Li, M., et al. (2000). 15-Deoxy-Δ12,14-prostaglandin J2 inhibits multiple steps in the NF-κB signalling pathway, Proc. Natl. Acad. Sci. USA 97, 4844–4849.
Su, C.-G., Wen, X., Bailey, et al. (1999). A novel therapy for colitis utilizing PPAR-γ ligands to inhibit the epithelial inflammatory response, J. Clin. Invest. 104, 383–389.
Takahashi, S., Fujita, T. and Yamamoto, A. (2001). Role of nuclear factor-κB in gastric ulcer healing in rats, Am. J. Physiol. 280, G1296–G1304.
Tsukimi, Y., Nakai, H., Itoh, S., et al. (2001). Involvement of heat shock proteins in the healing of acetic acid-induced gastric ulcers in rats, J. Physiol. Pharmacol. 52, 391–406.
Villegas, J., Martin, A. R., Tana, W., et al. (2004). Rosiglitazone, an agonist of peroxisome proliferator-activated receptor gamma, protects against ischemia-reperfusion damage in rats: role of oxygen free radicals generation, Eur. J. Pharmacol. 505, 195–203.
Yamakawa, K., Hosoi, M., Koyama, H., et al. (2000). Peroxisome proliferator-activated receptor-gamma agonists increase vascular endothelial growth factor expression in human vascular muscle cells, Biochem. Biophys. Res. Commun. 271, 571–574.
Yoo, C. G., Lee, S., Lee, Ch.-T., et al. (2000). Anti-inflammatory effect of heat shock protein induction is related to stabilization of NFκB through preventing IκB kinase activation in respiratory epithelial cells, J. Immunol. 164, 5416–5423.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Brzozowski, T., Konturek, P.C., Pajdo, R. et al. Agonist of peroxisome proliferator-activated receptor gamma (PPAR-γ: A new compound with potent gastroprotective and ulcer healing properties. Inflammopharmacol 13, 317–330 (2005). https://doi.org/10.1163/156856005774423908
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1163/156856005774423908